Dr Reddy Labs enters in voluntary licensing agreement with Eli Lilly to access it’s Covid treatment in India
May 12, 2021, at 09:48 pm
Hyderabad/UNI: Dr Reddy’s Laboratories on Wednesday announced that it has entered into a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly and Company (“Lilly”) for the manufacture and commercialization of the drug Baricitinib in India.